Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
54.4M
-
Shares change
-
-106K
-
Total reported value, excl. options
-
$266M
-
Value change
-
-$5.6M
-
Put/Call ratio
-
0.87
-
Number of buys
-
72
-
Number of sells
-
-69
-
Price
-
$4.88
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q2 2022
165 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q2 2022.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.4M shares
of 127M outstanding shares and own 42.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.68M shares), STATE STREET CORP (6.17M shares), Soleus Capital Management, L.P. (5.29M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4.45M shares), VANGUARD GROUP INC (4.2M shares), FEDERATED HERMES, INC. (2.59M shares), Assenagon Asset Management S.A. (2M shares), GEODE CAPITAL MANAGEMENT, LLC (1.3M shares), GOLDMAN SACHS GROUP INC (1.05M shares), and Granahan Investment Management, LLC (992K shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.